SNTI · Forms 3, 4, 5
Insider trades at Senti Biosciences Holdings, Inc.
No open-market insider buys or sells at Senti Biosciences Holdings, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Senti Biosciences Holdings, Inc. (SNTI) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Senti Biosciences Holdings, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Tax withholding | 10,757 | Form 4 | |||
| Timothy K Lu | CEO | Tax withholding | 80,666 | Form 4 | |||
| Kanya Rajangam | Pres. & Chief Med. & Dev. Off. | Tax withholding | 1,384 | Form 4 | |||
| Timothy K Lu | CEO | Tax withholding | 4,191 | Form 4 | |||
| Bryan Daniel Baum | Director | Options or other derivatives | Form 4 | ||||
| Bryan Daniel Baum | Director | Became an insider (Form 3) | Form 3 | ||||
| James J. Collins | Director | Options or other derivatives | Form 4 | ||||
| Feng Hsiung | Director | Options or other derivatives | Form 4 | ||||
| Fran Schulz | Director | Options or other derivatives | Form 4 | ||||
| Brenda Cooperstone | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.